BAZ2B Inhibitor Screening Assay Kit
924.15 €
In Stock
quantity
product details
Catalog number: 421 - 32600
Product Category: Business & Industrial > Science & Laboratory
Gentaur
Size: 384 rxns.
32521
BRD1 Inhibitor Screening Assay Kit
The BRD1 Inhibitor Screening Assay Kit is designed to measure the inhibition of BRD1 binding to its substrate. The key to the BRD1 Inhibitor Screening Assay Kit is the specific binding of the BRD1 bromodomain to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing BRD1 and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.
924.15 €
32601
ATAD2A Inhibitor Screening Assay Kit
The ATAD2A Inhibitor Screening Assay Kit is designed to measure the inhibition of ATAD2A binding to its substrate. The key to the ATAD2A Inhibitor Screening Assay Kit is a specific binding of the ATAD2A bromodomain to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing ATAD2A and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.
1704.38 €
32605
ATAD2B Inhibitor Screening Assay Kit
The ATAD2B Inhibitor Screening Assay Kit is designed to measure the inhibition of ATAD2B binding to its substrate. The key to the kit is the specific binding of the ATAD2B bromodomain to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing ATAD2B and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.
1704.38 €
32624
TAF1 (BD2) Inhibitor Screening Assay Kit
The TAF1 (BD2) Inhibitor Screening Assay Kit is designed to measure the inhibition of TAF1 (BD2) binding to its substrate. The key to the TAF1 (BD2) Inhibitor Screening Assay Kit is the specific binding of the TAF1 bromodomain 2 (a.a. 1519-1651) to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing TAF1 (BD2) and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.
1704.38 €
72008
BTLA:HVEM[Biotinylated] Inhibitor Screening Assay Kit
The BTLA:HVEM[Biotinylated] Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of BTLA:HVEM signaling. The key to this kit is the high sensitivity of detection of biotin-labeled HVEM by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, BTLA is coated on a 96-well plate. Next, HVEM is incubated with BTLA on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can be measured using a chemiluminescence reader.
1772.55 €
72020
KEAP1-Nrf2 Inhibitor Screening Assay Kit
The Keap1:Nrf2 Inhibitor Screening Assay Kit is designed for_x000D_identification of inhibitors of Keap1:Nrf2 binding using fluorescence polarization. Using this kit, only one simple step on a microtiter plate is required for_x000D_Keap1:Nrf2 inhibitor screening reactions. The Keap1 protein and fluorescently labeled_x000D_Nrf2 peptide are incubated with a sample containing testing inhibitors for 30 minutes._x000D_The change in fluorescent polarization can then be measured using a fluorescence_x000D_reader.